Cipla

A handout photo of an experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP

Molnupiravir: Merck Greenlights Generic Manufacturing of Its COVID Pill

Earlier, Merck had signed bilateral licensing deals with eight...

moderna

Cipla Gets DCGI Nod to Import Moderna’s Vaccine for India: Sources

Payal Banerjee 29/06/2021

On June 28, Cipla – on behalf of the...

FILE PHOTO: Vials labelled "Moderna, Johnson & Johnson, Pfizer-BioNTech coronavirus disease (COVID-19) vaccine" are seen in this illustration picture

DCGI Relaxes Norms to Clear Foreign-Made COVID-19 Vaccines

The Wire Staff 02/06/2021

Vaccines which have been approved by select regulatory bodies...

FILE PHOTO: An ampule of Remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg

Generic Version of Remdesivir to Be Launched in India at Rs 4,800 per 100 mg Vial

Reuters 06/07/2020

Mylan's version comes after two Indian drugmakers, Cipla Ltd...

hal-gatewood-AypaEmWVH8I-unsplash1

COVID-19: Can We Push Pharma Innovation Without Giving Away Pricey Patents?

Chirantan Chatterjee 09/04/2020

Drugs and treatments remain increasingly the only way to...

hiv-kids

A Year Since Stock-Outs, India Continues Slow Roll-Out of Child-Friendly HIV Drugs

Anoo Bhuyan 17/09/2018

India, even as it rolls out a pilot programme...

26124325_7db3cc0e1a_b

Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India

Anup Soans 01/05/2017

In the absence of a standard drug regulatory mechanism,...